Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASXC
2851
DELISTED
Asensus Surgical, Inc.
ASXC
| $1.08M | ﹤0.01% |
581,567
-2,700
| -0.5% | -$6.06K |
|
|
CSTR
2852
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $1.07M | ﹤0.01% |
50,572
-265
| -0.5% | -$5.55K |
|
|
HTB
2853
HomeTrust Bancshares
HTB
$837M
| $1.07M | ﹤0.01% |
38,241
-77,080
| -67% | -$2.12M |
|
|
FREE
2854
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $1.07M | ﹤0.01% |
92,406
-315
| -0.3% | -$3.96K |
|
|
JNCE
2855
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $1.07M | ﹤0.01% |
143,585
-114,507
| -44% | -$709K |
|
2856
UFP Technologies
UFPT
$2.48B
| $1.06M | ﹤0.01% |
17,262
-791
| -4% | -$49.9K |
|
2857
Geron
GERN
$982M
| $1.06M | ﹤0.01% |
772,989
-1,408,234
| -65% | -$1.88M |
|
|
MRNS
2858
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.06M | ﹤0.01% |
92,766
+1,721
| +2% | +$23.7K |
|
2859
FTC Solar
FTCI
$40.1M
| $1.05M | ﹤0.01% |
13,494
+44
| +0.3% | +$4.45K |
|
2860
Bioventus
BVS
$1.17B
| $1.04M | ﹤0.01% |
73,683
+13,602
| +23% | +$209K |
|
|
ICPT
2861
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.04M | ﹤0.01% |
70,211
-116,382
| -62% | -$1.86M |
|
2862
CEL-SCI Corp
CVM
$26M
| $1.04M | ﹤0.01% |
3,150
+93
| +3% | +$27.1K |
|
2863
Bar Harbor Bankshares
BHB
$681M
| $1.03M | ﹤0.01% |
36,583
+304
| +0.8% | +$8.41K |
|
|
KBAL
2864
DELISTED
Kimball International
KBAL
| $1.02M | ﹤0.01% |
91,388
-158,766
| -63% | -$1.95M |
|
|
TRUE
2865
DELISTED
TrueCar
TRUE
| $1.02M | ﹤0.01% |
245,451
-397,152
| -62% | -$1.84M |
|
|
AMNB
2866
DELISTED
American National Bankshares Inc
AMNB
| $1.02M | ﹤0.01% |
30,803
+170
| +0.6% | +$5.45K |
|
2867
American Superconductor
AMSC
$1.53B
| $1.01M | ﹤0.01% |
69,351
+2,978
| +4% | +$41.3K |
|
2868
Farmers National Banc Corp
FMNB
$970M
| $1.01M | ﹤0.01% |
64,405
-33
| -0.1% | -$507 |
|
2869
Identive
INVE
$64.1M
| $1.01M | ﹤0.01% |
53,568
+1,449
| +3% | +$24.6K |
|
2870
Southern First Bancshares
SFST
$612M
| $1.01M | ﹤0.01% |
18,861
+629
| +3% | +$31.8K |
|
|
XONE
2871
DELISTED
The ExOne Company
XONE
| $1.01M | ﹤0.01% |
43,163
-29
| -0.1% | -$608 |
|
2872
Tarsus Pharmaceuticals
TARS
$3.02B
| $1.01M | ﹤0.01% |
46,766
+193
| +0.4% | +$4.78K |
|
|
BLFY
2873
DELISTED
Blue Foundry Bancorp
BLFY
| $997K | ﹤0.01% |
+72,268
| New | +$970K |
|
2874
Rimini Street
RMNI
$470M
| $996K | ﹤0.01% |
103,127
-5,228
| -5% | -$45.3K |
|
2875
CNB Financial Corp
CCNE
$1.04B
| $994K | ﹤0.01% |
40,838
-300
| -0.7% | -$7.2K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.